Jacobi Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Jacobi Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-427	Closed	-$24K	–	1403
2020 Q4	$24K	Hold	427	–	–	﹤0.01%	685
2020 Q3	$20K	Hold	427	–	–	﹤0.01%	670
2020 Q2	$25K	Hold	427	–	–	﹤0.01%	597
2020 Q1	$20K	Buy	+427	New	+$23.8K	﹤0.01%	574
2016 Q4	–	Sell	-37	Closed	-$1K	–	653
2016 Q3	$1K	Hold	37	–	–	﹤0.01%	692
2016 Q2	$1K	Buy	+37	New	+$1.19K	﹤0.01%	686

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jacobi Capital Management's IONS Position: Q1 2021 in Review

Jacobi Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 427 shares — an estimated $24K sold.

Jacobi Capital Management first reported a position in IONS in Q2 2016 and held it in 6 quarters. The position peaked at $25K in Q2 2020. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

Jacobi Capital Management reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Jacobi Capital Management sold 427 Ionis Pharmaceuticals shares in Q1 2021, an estimated $24K.
Jacobi Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2016 and held it in 6 quarters.
Jacobi Capital Management's Ionis Pharmaceuticals position peaked at $25K in Q2 2020.
364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.